Status:
UNKNOWN
Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan
Lead Sponsor:
Kazakhstan Scientific Society for Study of intestine diseases
Collaborating Sponsors:
FERRING Kazakhstan
Conditions:
Ulcerative Colitis Chronic
Crohn Disease Colon
Eligibility:
All Genders
18+ years
Brief Summary
The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.
Detailed Description
The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of heal...
Eligibility Criteria
Inclusion
- Availability of a signed informed consent form; or the presence of a disinterested witness if the patient is unable to examine and sign the consent form due to illiteracy or disability (for example, in the case of blindness);
- The patient has a documented diagnosis of ulcerative colitis or Crohn's disease (endoscopy, histology, if indicated by radiation diagnostics);
- Patients who have applied for treatment or are already taking treatment from a gastroenterologist / coloproctologist, including inpatients;
- Citizenship of the Republic of Kazakhstan (or resides).
Exclusion
- Patient takes part in an interventional clinical trial;
- Patient is unable to follow the schedule of the visits;
- Any condition that the PI believes would prevent a study participant from participating in the study.
Key Trial Info
Start Date :
December 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05189327
Start Date
December 10 2021
End Date
December 31 2024
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Health Clinic #5
Almaty, Kazakhstan